Heart drug tested as migraine shield in small trial
NCT ID NCT04853797
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether ivabradine, a medicine used for heart conditions, could stop migraines triggered by another drug called levcromakalim. 37 adults with migraine without aura took part. The goal was to see if ivabradine could reduce the number of migraines caused by the trigger, helping researchers understand how migraines start.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEADACHE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Danish Headache Center
Glostrup Municipality, 2600, Denmark
-
Danish Headache Centre, Rigshospitalet-Glostrup
Glostrup, Region Sjælland, 2600, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a numbing nose treatment stop migraine pain in its tracks?
- Could a symptom registry unmask hidden migraine variants?
- Can a quick neck adjustment change deep headache muscles?
- Real-world study tests migraine drug atogepant over 12 months in tough-to-treat patients
- Could a common numbing drug ease Post-Brain bleed headaches?
- Scientists aim to forecast migraine pain using wearable sensors and early symptoms